Bacterial Infections in the Immunocompromised Host

Susanna Cunningham-Rundles; Mirjana Nesin

doi:10.1128/9781555818104.ch8

Chapter 8 : Bacterial Infections in the Immunocompromised Host

Authors: Susanna Cunningham-Rundles¹, Mirjana Nesin²

VIEW AFFILIATIONS HIDE AFFILIATIONS

Affiliations: 1: Immunology Research Laboratory, Division of Hematology and Oncology, Department of Pediatrics, Cornell University Weill Medical College-The New York Presbyterian Hospital, New York, NY 10021; 2: Perinatology Center, Division of Neonatology, Department of Pediatrics, Cornell University Weill Medical College-The New York Presbyterian Hospital, New York, NY 10021

Content Type: Monograph

Publication Year: 2000

Category: Bacterial Pathogenesis

Book DOI: 10.1128/9781555818104

Chapter DOI: 10.1128/9781555818104.ch8

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:

Bacterial Infections in the Immunocompromised Host, Page 1 of 2

< Previous page | Next page > /docserver/preview/fulltext/10.1128/9781555818104/9781555811594_Chap08-1.gif /docserver/preview/fulltext/10.1128/9781555818104/9781555811594_Chap08-2.gif

Abstract:

This chapter focuses on bacterial infections in specific settings where fundamental relationships relevant to the persistence of bacterial infections in the human host may be observed and studied. Neonates usually acquire bacterial pathogens transplacentally through the umbilical vein or by aspiration from amniotic fluid or cervical secretions. The complement system is able directly to lyse some gram-negative bacteria even in the absence of specific antibodies, but circulating levels of complement in the sera of neonates are lower than those in adults. Both the infected fetus and the neonate are able to produce protective IgM antibodies in response to bacterial antigens, but the levels in serum are lower than those in adults. The primary T-cell deficiencies produce defects in the cytokine production that is required to activate macrophages to kill intracellular bacteria. A primary defect of superoxide synthesis or adhesion of neutrophils is related to severe infection with pyogenic bacteria. The extreme example of acquired immune deficiency is human immunodeficiency virus (HIV) infection, which produces AIDS. Persistent infections modulate all aspects of immune response, including both adaptive and natural immune functions, and have long-term consequences for immune defense. Although encounters with bacteria are a normal aspect of neonatal life, infants are also more susceptible to bacterial infections than are adults.

Citation: Cunningham-Rundles S, Nesin M. 2000. Bacterial Infections in the Immunocompromised Host, p 145-163. In Nataro J, Blaser M, Cunningham-Rundles S (ed), Persistent Bacterial Infections. ASM Press, Washington, DC. doi: 10.1128/9781555818104.ch8

Key Concept Ranking

Tumor Necrosis Factor alpha: 0.46228445
Highly Active Antiretroviral Therapy: 0.40940922
Major Histocompatibility Complex: 0.40712455

0.46228445

Highlighted Text: Show | Hide

Full text loading...

Figures

Bacterial Infections in the Immunocompromised Host

[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555818104.chap8-1,webId=/content/author/10.1128/9781555818104.chap8-1,properties={foaf_givenname=Susanna, foaf_name=Susanna Cunningham-Rundles, foaf_surname=Cunningham-Rundles, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555818104.chap8-aff1]]}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555818104.chap8-2,webId=/content/author/10.1128/9781555818104.chap8-2,properties={foaf_givenname=Mirjana, foaf_name=Mirjana Nesin, foaf_surname=Nesin, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555818104.chap8-aff2]]}]]

/content/10.1128/9781555818104.chap8.fig8-1

FIGURE 1

Neonatal NK cell activity in response to bacteria. The data show the effect of S. marcescens, prepared as ribosomal vesicles, and S. pyogenes, prepared as whole inactivated cells, on neonatal NK effector cell function against the K562 target in the 4-h short-term 51Cr release assay following 18 h of pretreatment compared to endogenous activity at different effector-to-target ratios.

10.1128/9781555818104/fig8-1_thmb.gif

10.1128/9781555818104/fig8-1.gif

FIGURE 1

/content/10.1128/9781555818104.chap8.fig8-2

FIGURE 2

Production of IFN-γ in response to S. pyogenes. The data show the production of IFN- γ by adult and neonatal mononuclear cells in response to S. pyogenes after 18 h of culture.

10.1128/9781555818104/fig8-2_thmb.gif

10.1128/9781555818104/fig8-2.gif

FIGURE 2

Production of IFN-γ in response to S. pyogenes. The data show the production of IFN- γ by adult and neonatal mononuclear cells in response to S. pyogenes after 18 h of culture.

/content/10.1128/9781555818104.chap8.fig8-3

FIGURE 3

Superoxide production in phagocytes. The data show a deficient monocyte respiratory burst in response to E. coli and phorbol myristate acetate in a child on two test dates compared with normal controls. The data are shown as percent activated cells detected by flow cytometry.

10.1128/9781555818104/fig8-3_thmb.gif

10.1128/9781555818104/fig8-3.gif

FIGURE 3

/content/10.1128/9781555818104.chap8.fig8-4

FIGURE 4

Lymphocyte response to lactobacilli in HIV-infected children. The data show mononuclear cell response to lactobacilli in vitro in HIV+ children with low CD4+ T-cell numbers (mean, 7%) compared to children with better CD4+ T-cell numbers (mean, 34%).

10.1128/9781555818104/fig8-4_thmb.gif

10.1128/9781555818104/fig8-4.gif

FIGURE 4

References

/content/book/10.1128/9781555818104.chap8

1. Agematsu, K.,, H. Nagumo,, K. Shinozaki,, S. Hokibara,, K. Yasui,, K. Terada,, N. Kawamura,, T. Toba,, S. Nonoyama,, H. D. Ochs,, and A. Komiyama. 1998. Absence of IgDCD27 (+) memory B cell population in X-linked hyper-IgM syndrome. J. Clin. Investig. 102: 853– 860.

2. Alenghat, E. E.,, and J. R. Sterly. 1984. Alveolar macrophages in perinatal infants. Pediatrics 74: 221– 223.

3. Baltimore, R. S. 1998. Neonatal nosocomial infections. Semin. Perinatol. 22: 25– 32.

4. Barnes, P. F.,, and R. L. Modlin. 1996. Human cellular immune responses to Mycobacterium tuberculosis. Curr. Top. Microbiol. Immunol. 215: 197– 219.

5. Beaugerie, L.,, B. Salauze,, A. Bure,, A. M. Deluol,, N. Hoyeau-Idrissi,, F. Carbonnel,, Y. Ngo,, J. Cosnes,, W. Rozenbaum,, J. C. Nicolas,, and J. Gendre. 1996. Results of culture from colonoscopically obtained specimens for bacteria and fungi in HIV-infected patients with diarrhea. Gastrointest. Endosc. 44: 663– 666.

6. Benator, D. A.,, and F. M. Gordin. 1996. Nontuberculous mycobacteria in patients with human immunodeficiency virus infection. Semin. Respir. Infect. 11: 285– 300.

7. Bengmark, S.,, and B. Jeppsson. 1995. Gastrointestinal surface protection and mucosa reconditioning. J. Parenter. Enteral Nutr. 19: 410– 415.

8. Berner, R.,, C. M. Niemeyer,, J. U. Leititis,, A. Funke,, C. Schwab,, U. Rau,, K. Richter,, M. S. Tawfeek,, M. Clad,, and M. Brandis. 1998. Plasma levels and gene expression of GCSF, TNF-alpha, IL-lbeta, IL-6, IL-8 and soluble intercellular adhesion molecule in neonatal early onset sepsis. Pediatr. Res. 44: 469– 477.

9. Berthet, F.,, F. Le Deist,, A. M. Duliege,, and C. Griscelli. 1994. Clinical consequences and treatment of primary immunodeficiency syndromes characterized by functional T and B lymphocyte anomalies (combined immune deficiency). Pediatrics 93: 265– 270.

10. Boes, M.,, A. P. Prodeus,, T. Schmidt,, M. C. Carroll,, and J. Chen. 1998. A critical role of natural immunoglobuHn M in immediate defense against systemic bacterial infection. J. Exp. Med. 188: 2381– 2386.

11. Bohnsack, J. F.,, K. Vidjaja,, S. Ghazizadeh,, C. E. Rubens,, D. R. Hilhyard,, C. J. Parker,, K. H. Ablertne,, and H. R. Hill. 1997. A role for C5a and C5-ase in the acute neutrophil response to group B streptococcal infections. J. Infect. Dis. 175: 847– 855.

12. Boullierin, S.,, Y. Poquet,, T. Debord,, J. J. Fournie,, and M. L. Gougeon, 1999. Regulation by cytokines (IL-12, IL-15, IL-4 and IL-10) of the V gamma9Vdelta2 T cell response to mycobacterial phosphoantigens in responder and anergic HIV-infected persons. Eur. J. Immunol. 29: 90– 99.

13. Brown, T. A.,, R. Jonsson,, and B. Haneberg. 1998. Cervical secretions in pregnant women colonized rectally with group B streptococci have high levels of antibodies to serotype III polysaccharide capsular antigen and protein R. Scand. J. Immunol. 47: 179– 188.

14. Buckley, R.H., 1996. Primary immunodeficiencydisease, p. 1401– 1408. In J. C. Bennett, and F. Plum (ed.), Cecil Textbook of Medicine. W. B. Saunders Co., Philadelphia, Pa.

15. Buhrer, C.,, J. Graulich,, D. Stibenz,, J. W. Dudenhousen,, and M. Obladen. 1994. L-selection is down-regulated in umbilical cord blood granulocytes and monocytes of newborn infants with acute bacterial infection. Pediatr. Res. 36: 799– 804.

16. Campos-Neto, A.,, P. Ovendale,, T. Bement,, T. A. Koppi,, W. C. Fanslow,, M. A. Rossi,, and M. R. Alderson. 1998. CD40 ligand is not essential for the development of cell-mediated immunity and resistance to Mycobacterium tuberculosis. J. Immunol. 160: 2037– 2041.

17. Caperna, J.,, R. E. Barber,, J. G. Toerner,, and W. C. Mathews. 1998. Estimation of the effect of neutropenia on rates of clinical bacteraemia in HIV-infected patients. Epidemiol. Infect. 120: 71– 80.

18. Carson, P. J.,, R. L. Schut,, M. L. Simpson,, J. O'Brien,, and E. N. JanofF. 1995. Antibody class and subclass responses to pneumococcal polysaccharides following immunization o f human immunodeficiency virus-infected patients. J. Infect. Dis. 172: 340– 345.

19. Caux, C.,, C. Dezutter-Dambuyant,, D. Schmitt,, and J. Banchereau. 1992. GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature 360: 258– 261.

20. Craven, D. E. 1995. Staphylococcus aureus colonisation and bacteraemia in persons infected with human immunodeficiency virus: a dynamic interaction with the host. J. Chemother. 7 (Suppl. 3): 19– 28.

21. Cunningham-Rundles, C.,, F. P. Siegal,, S. Cunningham-Rundles,, and P. Lieberman. 1987. Incidence of cancer in 98 patients with common varied immunodeficiency in the United States. Clin. Immunol. 7: 294– 303.

22. Cunningham-Rundles, S.,, S. Arne,, S. Bengmark,, R. Johann-Liang ,, F. Marshall,, L. Metakis,, C. Califano,, A. M. Dun,, C. Grassey,, G. Hinds,, and J. Cervia. Probiotics and immune response. J. Gastroenterol, in press.

23. Cunningham-Rundles, S.,, C. Chen,, J. B. Bussel,, C. Blankenship,, M. B. Veber,, D. Sanders-Laufer,, T. Hinds,, J. S. Cervia,, and P. Edelson. 1995. Human immune development: implications for congenital HIV infection. Ann. N.Y. Acad. Sci. 693: 70– 84.

24. Cunningham-Rundles, S.,, and F. P. Pearson. 1990. ImuVert activation of natural killer cytotoxicity and interferon gamma production via CD 16 triggering. Int. J. Immunopharmacol. 12: 589– 598.

25. Cunningham-Rundles, S. 1994. Malnutrition and gut immune function. Curr. Opin. Gastroenterol 10: 664– 670.

26. Cusumano, V.,, V. Mancuso,, F. Genovese,, M. Cuzzola,, M. Carbone,, J. A. Cook,, J. B. Cochran,, and G. Teti. 1997. Neonatal hypersusceptibility to endotoxin correlates with increased TNF production in mice. J. Infect. Dis. 176: 168– 176.

27. Dai, W. J.,, G. Kohler,, and F. Brombacher. 1997. Both innate and acquired immunity to Listeria monocytogenes infection are increased in IL-10-deficient mice. J. Immunol 158: 2259– 2267.

28. Deerojanawong, J.,, A. B. Chang,, P. A. Eng,, C. F. Robertson,, and A. S. Kemp. 1997. Pulmonary diseases in children with severe combined immune deficiency and DiGeorge syndrome. Pediatr. Pulmonol 24: 324– 330.

29. Denis, M.,, and E. Ghadirian. 1994. Mycobacterium avium infection in HIV-1-infected subjects increases monokine secretion and is associated with enhanced viral load and diminished immune response to viral antigens. Clin. Exp. Immunol. 97: 76– 82.

30. Derkx, H. H.,, E. I. Kuijper,, C. A. Fijen,, M. Jak,, J. Dankert,, and S. J. van Deventer. 1995. Inherited complement deficiency in children surviving fulminant meningococcal septic shock. Eur. J. Pediatr. 154: 735– 738.

31. Devis, C. A.,, E. H. Vallota,, and J. Forristal. 1979. Serum complement level in infancy; age related changes. Pediatr. Res. 13: 1043– 1046.

32. Drago, L.,, M. R. Gismondo,, A. Lombardi,, C. de Haen ,, and L. Gozzini. 1997. Inhibition of in vitro growth of enteropathogens by new Lactobacillus isolates of human intestinal origin. FEMS Microbiol Lett. 153: 455– 463.

33. Duchmann, R.,, I. Kaiser,, E. Hermann,, W. Mayet,, K. Ewe,, and K. H. Meyer zum Buschenfelde. 1995. Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD). Clin. Exp. Immunol 102: 448– 455.

34. Ekdahl, K.,, J. H. Braconier,, and C. Svanborg. 1997. Impaired antibody response to pneumococcal capsular polysaccharides and phosphorylcholine in adult patients with a history of bacteremic pneumococcal infection. Clin. Infect. Dis. 25: 654– 660.

35. Ewert, D.P.,, L. Lieb,, P. S. Hayes,, M. W. Reeves,, and L. T. I. Mascola. 1995. Listeria monocytogenesinfection and serotype distribution among HIV-infected persons in Los Angeles County, 1985-1992. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol 8: 461– 465.

36. Fidler, S. J.,, I. Dorrell,, S. Ball,, G. Lombardi,, J. Weber,, C. Hawrylowicz,, and A. D. Rees. 1996. An early antigen-presenting cell defect in HIV-1-infected patients correlates with CD4 dependency in human T-cell clones. Immunology 89: 46– 53.

37. Figueroa, J. E.,, and P. Densen. 1991. Infectious disease associated with complement deficiencies. Clin. Microbiol. Rev. 4: 359– 395.

38. Fiorentino, D. F.,, A. Zlotnik,, T. R. Mosman,, M. Howard,, and A. O'Garra. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147: 3815– 3822.

39. Fischetti, V. A.,, D. Medaglini,, and G. Pozzi. 1996. Gram-positive commensal bacteria for mucosal vaccine delivery. Curr. Opin. Biotechnol 7: 659– 666.

40. French, M. A.,, K. A. Denis,, R. Dawkins,, and J. B. Peter. 1995. Severity of infections in IgA deficiency: correlation with decreased serum antibodies to pneumococcal polysaccharides and decreased serum IgG2 and/or IgG4. Clin. Exp. Immunol. 100: 47– 53.

41. Fujiwara, T.,, T. Kobayashi,, J. Takaya,, S. Taniuchi,, and J. Kobayashi. 1997. Plasma effects on phagocytic activity and hydrogen peroxide production by PMNs in neonates. Clin. Immunol Immunopathol. 85: 67– 72.

42. Gao, J. X.,, and A. C. Issekutz. 1995. PMN migration through human dermal fibroblast monolayers is dependent on beta 2 integrin and beta 1 integrin mechanisms. Immunology 85: 485– 494.

43. Garcia, V. E.,, P. A. Sieling,, J. Gong ,, P. F. Barnes,, K. Uyemura,, Y. Tanaka,, B. R. Bloom,, C. T. Morita,, and R. L. Modlin. 1997. Single-cell cytokine analysis o f gamma delta T cell responses to nonpeptide mycobacterial antigens. J. Immunol 159: 1328– 1335.

44. Gellin, B.G.,, C. V. Broome,, and W. F. Bilb. 1991. The epidemiology oflisteriosis in the United States-1986. Am. J. Epidemiol 133: 392– 401.

45. Gemmell, C. G. 1995. Staphylococcal scalded skin syndrome. J. Med. Microbiol. 43: 318– 322.

46. Gladstone, I. M.,, R. A. Ehenkranz,, S. C. Edberg,, and R. S. Baltimore. 1990. A ten-year review o f neonatal sepsis and comparison with the previous fifty-year experience. Pediatr. Infect. Dis. J. 9: 819– 825.

47. Goletti, D.,, D. Weissman,, R. W. Jackson,, N. M. Graham,, D. Vlahov,, R. S. Klein,, S. S. MunsifF,, L. Ortona,, R. Cauda,, and A. S. Fauci. 1996. Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J. Immunol. 157: 1271– 1278.

48. Gong, J.,, S. Stenger,, J. A. Zack,, B. E. Jones,, G. C. Bristol,, R. L. Modlin,, P. J. Morrissey,, and P. F. Barnes. 1998. Isolation of mycobacterium- reactive CD1-restricted T cells from patients with human immunodeficiency virus infection. J. Clin. Investig. 101: 383– 389.

49. Gong, J. H.,, M. Zhang,, R. L. Modlin,, P. S. Linsley,, D. Iyer,, Y. Lin,, and P. F. Barnes. 1996. Interleukin-10 downregulates Mycobacterium tuberculosis-induced Thl responses and CTLA-4 expression. Infect. Immun. 64: 913– 918.

50. Gray, R. H.,, M. J. Wawer,, N. Sewankambo,, and D. Serwadda. 1997. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 350: 1780.

51. Grewal, I. S.,, and R. A. Flavell. 1997. The CD40 ligand. At the center of the immune universe? Immunol. Res. 16: 59– 70.

52. Gruenewald, R.,, S. Blum,, and J. Chan. Relationship between human immunodeficiencyvirus infection and salmonellosis in 20- to 59-year-old residents of New York City. Clin. Infect. Dis. 18: 358– 363.

53. Haas, D. W.,, M. M. Lederman,, L. A. Clough,, R. S. Wallis,, D. Chernoff,, and S. L. Crampton. 1998. Proinflammatory cytokine and human immunodeficiency virus R N A levels during early Mycobacterium avium complex bacteremia in advanced AIDS. J. Infect. Dis. 177: 1746– 1749.

54. Harrison, T. S.,, and S. M. Levitz. 1997. Priming with IFN-gamma restores deficient IL-12 production by peripheral blood mononuclear cells from HIV-seropositive donors. J. Immunol. 158: 459– 463.

55. Harrison, T. S.,, and S. M. Levitz. 1995. Interaction with human immunodeficiency virus type 1 modulates innate effector functions of human monocytes. J. Infect. Dis. 172: 1598– 1601.

56. Hassan, J.,, and D. J. Reen. 1996. Reduced primary antigen-specific T-cell precursor frequencies in neonates is associated with deficient interleukin-2 production. Immunology 87: 604– 608.

57. Haziot, A.,, B. Z. Tsuberi,, and S. M. Goyert. 1993. Neutrophil CD 14: biochemical properties and role in the secretion o f tumor necrosis factoralpha in response to lipopolysaccharide. J. Immunol. 150: 5556– 5565.

58. Hessle, C.,, L. A. Hanson,, and A. E. Wold. 1999. Lactobacilli from human gastro-intestinal mucosa are strong stimulators of IL-12 production. Clin. Exp. Immunol. 116: 276– 282.

59. Hibbs, J.R.,, J. M. Douglas, Jr.,, F.N. Judson,, W.L. McGill,, C.A. Rietmeijer,, and E.N. Janoff. 1997. Prevalence of human immunodeficiency virus infection, mortality rate, and serogroup distribution among patients with pneumococcal bacteremia at Denver General Hospital, 1984-1994. Clin. Infect. Dis. 25: 195– 199.

60. Hill, M.J. 1997. Intestinal flora and endogenousvitamin synthesis. Eur. J. Cancer Prev. 6( Suppl. 1): S43– S45.

61. Hobbs, J. R.,, and J. A. Davis. 1967. Serum gamma globulin levels and gestational age in premature babies. Lancet i: 757– 759.

62. Hoffman, A. A. 1981. Presentation o f antigen by human newborn monocytes to maternal tetanus toxoid-specific T cells. J. Clin. Investig. 1: 127.

63. Hogg, N.,, M. P. Stewart,, S. L. Scarth,, R. Newton,, J. M. Shaw,, S. K. Law,, and N. Klein. 1999. A novel leukocyte adhesion deficiency caused by expressed but nonfunctional beta2 integrins Mac-1 and LFA-l. J. Clin. Investig. 103: 97– 106.

64. Howard, A. M.,, and M. Cosyns. 1994. Proliferative and cytokine responses by human newborn T cells stimulated with staphylococcal enterotoxins. Pediatr. Res. 35: 293– 298.

65. Johansson, M.,, K. Schon,, M. Ward,, and N. Lycke. 1997. Genital tract infection with Chlamydia trachomatis fails to induce protective immunity in gamma interferon receptor-deficient mice despite a strong local immunoglobulin A response. Infect. Immun. 65: 1032– 1044.

66. Johansson, M. L.,, G. Molin,, B. Jeppsson,, S. Nobaek,, S. Ahrne,, and S. Bengmark. 1993. Administration of different Lactobacillus strains in fermented oatmeal soup: in vivo colonization of human intestinal mucosa and effect on the indigenous flora. Appl. Environ. Microbiol. 59: 15– 20.

67. Jouanguy, E.,, F. Altare,, S. Lamhamedi-Cherradi,, and J. L. Casanova. 1997. Infections in IFNGR-1 -deficient children. J. Interferon Cytokine Res. 17: 583– 587.

68. Kagi, D.,, B. Ledermann,, K. Burki,, H. Hengartner,, and R. M. Zinkernagel. 1994. CD8 + T cell-mediated protection against an intracellular bacterium by perforin-dependent cytotoxicity. Eur. J. Immunol. 24: 3068– 3072.

69. Keiser, P.,, E. Higgs,, and J. Smith. 1996. Neutropenia is associated with bacteremia in patients infected with the human immunodeficiency virus. Am. J. Med. Sci. 312: 118– 122.

70. Klein, J. O. 1990. From harmless commensal to invasive pathogen: coagulase negative staphylococci. N. Engl. J. Med. 323: 1– 3.

71. Klein, J. O.,, and S. M. Marcy,. 1995. Bacterial sepsis and meningitis, p. 847. In J. S. Remington, and J. O. Klein (ed.), Infectious Diseases of the Fetus and Newborn Infant, 4th ed. W. B. Saunders Co., Philadelphia, Pa.

72. Klein, J.O.,, and J. S. Remington,. 1995. Current concepts ofinfections of the fetus and newborn infant, p. 11– 13. In J. S. Remington, and J. O. Klein (ed.), Infectious Diseases of the Fetus and Newborn Infant, 4th ed. W. B. Saunders Co., Philadelphia, Pa.

73. Kotler, D. P. 1998. Intestinal disease associated with HIV infection: characterization and response to antiretroviral therapy. Pathobiology 66: 183– 188.

74. Kotler, D. P. 1998. Human immunodeficiency virus-related wasting: malabsorption syndromes. Semin. Oncol. 25 (Suppl. 6): 70– 75.

75. Kuan, S. F. 1992. Interactions of surfactant protein D with bacterial lipopolysaccharides. Surfactant protein D is an Escherichia coli-binding protein in bronchoalveolar lavage. J. Clin. Investig. 90: 97– 106.

76. Kurosawa, S.,, M. Harada,, Y. Shinomiya,, H. Terao,, and K. Nomoto. 1996. The concurrent administration of OK432 augments the antitumor vaccination effect with tumor cells by sustaining locally infiltrating natural killer cells. Cancer Immunol. Immunother. 43: 31– 38.

77. Laurence, J.,, D. Mitra,, M. Steiner,, D. H. Lynch,, F. P. Siegal,, and L. Staiano-Coico. 1996. Apoptotic depletion of CD4 + T cells in idiopathic CD4 + T lymphocytopenia. J. Clin. Investig. 97: 672– 680.

78. Laver, J.,, E. Duncan,, and M. Abboud. 1990. High levels of granulocyte and GM-CSF in cord blood of normal full term neonates. J. Pediatr. 116: 627– 632.

79. Lee, S. M.,, Y. Suen,, L. Chang,, V. Bruner,, J. Qian,, J. Indes,, E. Knoppel,, C. van de Ven,, and M. S. Cairo. 1996. Decreased interleukin-12 (IL-12) from activated cord versus adult peripheral blood mononuclear cells and upregulation of interferon-gamma, natural killer, and lymphokine-activated killer activity by IL-12 in cord blood mononuclear cells. Blood 88: 945– 954.

80. Levy, J.A. 1994. Viral studies of chronic fatiguesyndrome. Clin. Infect. Dis. 18( Suppl.1): S117– S120.

81. Lewis, D. A.,, A. Larsen,, and C. B. Wilson. 1986. Reduced interferon gamma mRNA levels in human neonates. J. Exp. Med. 163: 1018– 1023.

82. Lichenstein, R.,, J. C. King, Jr.,, J. J. Farley,, P. Su,, P. Nair,, and P. E. Vink. 1998. Bacteremia in febrile human immunodeficiency virusinfected children presenting to ambulatory care settings. Pediatr. Infect. Dis. J. 17: 381– 385.

83. Madoff, L. C. 1994. Maternal immunization of mice with group B streptococcal type III polysaccharide beta C protein conjugate elicits protective antibodies to multiple serotypes. J. Clin. Investig. 94: 286– 292.

84. MadofF, L. C.,, J. L. Michel,, E. W. Gong,, D. E. Kling,, and D. L. Kager. 1996. Group B streptococci escape host immunity by deletion of tandem repeat elements of the alpha C protein. Proc. Natl. Acad. Sci. USA 93: 4131– 4136.

85. Mahon, B.P.,, B. J. Sheahan,, F. Griffin,, G. Murphy,, and K. H. Mills. 1997. Atypical disease after Bordetellapertussis respiratory infection of mice with targeted disruptions of interferongamma receptor or immunoglobulin mu chain genes. J. Exp. Med. 186: 1843– 1851.

86. Manroe, B. L.,, A. G. Weinberg,, and C. R. Rosenfeld. 1979. The neonatal blood count in health and disease. J. Pediatr. 95: 89– 98.

87. Medaglini, D.,, G. Pozzi,, T. P. King,, V. A. Fischetti. 1995. Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization. Proc. Natl. Acad. Sci. USA 92: 6868– 6872.

88. Mellander, L.,, B. Carlsson,, F. Jelil,, T. Soderstrom,, and L. A. Hanson. 1985. Secretory IgA antibody response against E. coli antigens in infants in relation to exposure. J. Pediatr. 107: 430– 433.

89. Menzies, B. E.,, and I. Kourteva. 1998. Internalization of Staphylococcus aureus by endothelial cells induces apoptosis. Infect. Immun. 66: 5994– 5998.

90. Merry, C.,, P. Puri,, and D. J. Reen. 1998. Phosphorylation and the actin cytoskeleton in defective newborn neutrophil chemotaxis. Pediatr. Res. 44: 259– 264.

91. Morell, A. 1994. Clinical relevance of IgG subclass deficiencies. Ann. Biol. Clin. (Paris). 52: 49– 52.

92. Moroni, M.,, and F. Franzetti. 1995. Bacterial pneumonia in adult patients with HIV infection. J. Chemother. 7: 292– 306.

93. Morris, J. G., Jr.,, and M. Potter. 1997. Emergence of new pathogens as a function of changes in host susceptibility. Emerg. Infect. Dis. 3: 435– 440.

94. Murray, J. F. 1998. Tuberculosis and HIV infection: a global perspective. Respiration 65: 335– 342.

95. Newman , G. W.,, J. R. Guarnaccia,, E. A. Vance III,, J. Y. Wu,, H. G. Remold ,, and P. H. Kazanjian, Jr. 1994. Interleukin-12 enhances antigen-specific proliferation of peripheral blood mononuclear cells from HIV-positive and negative donors in response to Mycobacterium avium. AIDS 8: 1413– 1419.

96. Nguyen, M. H.,, C. A. Kauffinan,, R. P. Goodman,, C. Squier,, R. D. Arbeit,, N. Singh,, M. M. Wagener,, and V. L. Yu. 1999. Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients. Ann. Intern. Med. 130: 221– 225.

97. Nicoletti, F.,, G. Mancuso,, V. Cusumano,, R. DiMarco,, P. Zaccone,, K. Benndtzen,, and G. Teti. 1997. Prevention of endotoxin induced lethality in neonatal mice by IL-13. Eur. J. Immunol. 27: 1580– 1583.

98. Nybo, M.,, O. Soversen,, R. Leslie,, and P. Wang. 1998. Reduced expression of C5a receptors on neutrophils from cord blood. Arch. Dis. Child. Fetal Neonatal Ed. 78: 129– 132.

99. Pasparakis, M.,, L. Alexopoulou,, V. Episkopou,, and G. Kollias. 1996. Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for T N F alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J. Exp. Med. 184: 1397– 1411.

100. Payne, N. R.,, and H. B. Fleit. 1996. Extremely l ow birth weight infants have lower Fc gamma RIII plasma levels and their PMN produce less Fc gamma compared to adults. Biol. Neonate 69: 235– 242.

101. Pierre-Audigier, C.,, E. Jouanguy,, S. Lamhamedi,, F. Altare,, J. Rauzier,, V. Vincent,, D. Canioni,, J. F. Emile,, A. Fischer,, S. Blanche,, J. L. Gaillard,, and J. L. Casanova. 1997. Fatal disseminated Mycobacterium smegmatis infection in a child with inherited interferon gamma receptor deficiency. Clin. Infect. Dis. 24: 982– 984.

102. Porcelli, S.,, C. T. Morita,, and M. B. Brenner. 1992. CDlb restricts the response of human CD4-8-T lymphocytes to a microbial antigen. Nature 360: 593– 597.

103. Prindull, G.,, and M. Ahmad. 1993. The ontogeny of the gut mucosal immune system and the susceptibility to infections in infants of developing countries. Eur. J. Pediatr. 152: 786– 792.

104. Rebuck, N. 1995. Neutrophil adhesion molecules in term and preterm infants: normal or enhanced leukocyte integrins but defective L selectin expression and shedding. Clin. Exp. Immunol. 101: 183– 189.

105. Rodriguez-Barradas, M. C.,, J. E. Groover,, C. E. Lacke,, D. W. Gump,, C. I. Lahart,, J. P. Pandey,, and D. M. Musher. 1996. IgG antibody to pneumococcal capsular polysaccharide in human immunodeficiency virus-infected subjects: persistence of antibody in responders, revaccination in nonresponders, and relationship of immunoglobulin allotype to response. J. Infect. Dis. 173: 1347– 1353.

106. Rogasi, P. G.,, S. Vigano,, P. Pecile,, and F. Leoncini. 1998. Lactobacillus casei pneumonia and sepsis in a patient with AIDS. Case report and review of the literature. Ann. Ital. Med. Int. 13: 180– 182.

107. Romagnani, S. 1995. Biology of human TH1 and TH2 cells. J. Clin. Immunol. 15: 121– 129.

108. Rowen, J. L.,, C. W. Smith,, and M. S. E dwards. 1995. Group B streptococci elicit leukotriene B 4 and IL-8 from human monocytes: neonates exhibit a diminished response. J. Infect. Dis. 172: 420– 426.

109. Rubens, C. E. 1992. Epithelial cell invasion by group B streptococci. Infect. Immun. 60: 5157– 5161.

110. Sampaio, E.P.,, J. R. Caneshi,, J. A. Nery,, N. C. Duppre,, G. M. Pereira,, L. M. Vieira,, A. L. Moreira,, G. Kaplan,, and E. N. Sarno. 1995. Cellular immune response to Mycobacterium leprae infection in human immunodeficiency virus-infected individuals. Infect. Immun. 63: 1848– 1854.

111. Schaumann, R.,, J. Krosing,, and P. M. Shah. 1998. Phagocytosis of Escherichia coli and Staphylococcus aureus by neutrophils of human immunodeficiency virus-infected patients. Eur. J. Med. Res. 3: 546– 548.

112. Schiffrin, E. J.,, F. Rochat,, H. Link-Amster,, J. M. Aeschlimann,, and A. Donnet-Hughes. 1995. Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J. Dairy Sci. 78: 491– 497.

113. Shroflf, K. E.,, K. Meslin,, and J. J. Cebra. 1995. Commensal enteric bacteria engender a self-Umiting humoral mucosal immune response while permanently colonizing the gut. Infect. Immun. 63: 3904– 3913.

114. Smith, D. H.,, G. Peter,, and D. L. Ingram. 1973. Responses of children immunized with capsular polysaccharides of Haemophilus influenzae. Pediatrics 52: 637– 644.

115. Sorensen, R. U.,, L. E. Leiva,, F. C. Javier III,, D. M. Sacerdote,, N. Bradford,, B. Butler,, P. A. Giangrosso,, and C. Moore. 1998. Influence of age on the response to Streptococcus pneumoniae vaccine in patients with recurrent infections and normal immunoglobulin concentrations. J. Allergy Clin. Immunol. 102: 215– 221.

116. Stoll, B. J.,, T. Gordon,, S. B. Korones,, S. Shankaron,, J. E. Tyson ,, C. R. Bauer,, A. A. FanarofF,, J. A. Lemons,, E. F. Donovan ,, W. Oh,, D. K. Stevenson,, R. A. Ehrenkanz,, L. A. Papile,, J. Verter,, and L. L. Wright. 1996. Late onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J. Pediatr. 129: 63– 71.

117. Stoll, B. J.,, T. Gordon,, S. B. Korones,, S. Shankaron,, J. E. Tyson,, C. R. Bauer,, A. A. FanarofF,, J. A. Lemons,, E. F. Donovan,, W. Oh,, D. K. Stevenson,, R. A. Ehrenkanz,, L. A. Papile,, J. Verter,, and L. L. Wright. 1996. Early onset sepsis in very l ow birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J. Pediatr. 129: 72– 80.

118. Taha, T. E.,, D. R. Hoover,, G. A. Dallabetta,, and N. I. Kumwenda. 1998. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS 12: 1699– 1706.

119. Tee, W.,, and A. Mijch. 1998. Campylobacter jejuni bacteremia in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients: comparison o f clinical features and review. Clin. Infect. Dis. 26: 91– 96.

120. Teti, G.,, G. Mancuso,, and F. Tomasello. 1993. Cytokine appearance and effects of anti- TNF alpha antibodies in a neonatal rat model of group B streptococcal infection. Infect. Immun. 61: 227– 235.

121. Tossing, G. 1996. Immunodeficiency and itsrelation to lymphoid and other malignancies. Ann. Hematol. 73: 163– 167.

122. Tsukada, H.,, I. Kawamura,, and M. Arakawa. 1991. Dissociated development of T cells mediating delayed-type hypersensitivity and protective T cells against Listeria monocytogenes and their functional difference in lymphokine production. Infect. Immun. 59: 3589– 3595.

123. Veber, M. B.,, S. Cunningham-Rundles,, M. Schulman,, F. Mandel,, and P. A. M. Auld. 1991. Acute shift in immune response to microbial activators in very low birthweight infants. Clin. Exp. Immunol. 83: 391– 395.

124. Wagner, R. D.,, T. Warner,, L. Roberts,, J. Farmer,, and E. Balish. 1997. Colonization of congenitally immunodeficient mice with probiotic bacteria. Infect. Immun. 65: 3345– 3351.

125. Winkelstein, J. A., 1998. The complementsystem in the fetus and newborn, p. 1964– 1967. In R. A. Polin, and W. W. Fox (ed.), Fetal and Neonatal Physiology, 2nd ed. W.B. Saunders Co., Philadelphia, Pa.

126. Wolbink, G. J.,, A. W. Bossink,, A. B. Groneweld ,, M. C. de Grott,, L. G. Thijs,, and C. E. Hack. 1998. Complement activation in patients with sepsis is in part mediated by Creactive protein. J. Infect. Dis. 177: 81– 87.

127. Wolf, B. W.,, K. B. Wheeler,, D. G. Ataya,, and K. A. Garleb. 1998. Safety and tolerance of Lactobacillus reuteri supplementation to a population infected with the human immunodeficiency virus. Food Chem. Toxicol. 36: 1085– 1094.

128. Woods, M. L., II,, R. MacGinley,, D. P. Eisen,, and A. M. Allworth. 1998. HIV combination therapy: partial immune restitution unmasking latent cryptococcal infection. AIDS 12: 1491– 1494.

129. Wright, J.R.,, and D. C. Youmansi. 1993. Pulmonary surfactantprotein A stimulates chemotaxis of alveolar macrophage. Am. J.Physiol. 264: L338– L344.

130. Yang, X.,, and R. C. Brunham. 1998. Gene knockout B cell-deficient mice demonstrate that B cells play an important role in the initiation of T cell responses to Chlamydia trachomatis (mouse pneumonitis) lung infection. J. Immunol. 161: 1439– 1446.

131. Yap, P.L. 1994. Does intravenous immune globulinhave a role in HIV-infected patients? Clin. Exp. Immunol. 97( Suppl. l): 59– 67.

132. Yegin, O. 1983. Chemotaxis in childhood. Pediatr. Res. 17: 183– 187.

133. Zerlauth, G.,, E. Maier,, H. Chehadeh,, K. Zimmermann,, M. M. Eibl,, and J. W. Mannhalter. 1995. Interaction with human immunodeficiency virus type 1 modulates innate effector functions of human monocytes. J. Infect. Dis. 172: 1598– 1601.

134. Zhang, Y.,, K. Nakata,, M. Weiden,, and W. N. Rom. 1995. Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication by transcriptional activation at the long terminal repeat. J. Clin. Investig. 95: 2324– 2331.

135. Zlabinger, G. J. 1983. Cord blood macrophages present bacterial antigen (E. coli) to paternal T cells. Clin. Immunol. Immunopathol. 28: 405– 412.

136. Zybarth, G.,, N. Reiling,, H. Schmidtmayerova,, B. Sherry,, and M. Bukrinsky. 1999. Activation-induced resistance of human macrophages to HIV-1 infection in vitro. J. Immunol. 162: 400– 406.

Tables

Bacterial Infections in the Immunocompromised Host

/content/10.1128/9781555818104.chap8.tab8-1

TABLE 1

Bacterial infections in primary immune deficiency

10.1128/9781555818104/tab8-1_thmb.gif

10.1128/9781555818104/tab8-1.gif

TABLE 1

Bacterial infections in primary immune deficiency